Page results
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
File results
-
FOI/2021/0419 - Sexual orientation workforce
-
FOI/2021/0426 - CAMHS treatment
-
FOI/2021/0430 - Neurorehabilitation
-
FOI/2021/0431 - Data Security and Protections Toolkit
-
FOI/2021/0433 - Breathing circuits and filters
-
FOI/2021/0438 - Dermatology service costs and contract values
-
FOI/2021/0440 - Windows 7 and XP in operation
-
FOI/2021/0441 - Unvacinated Covid inpatients
-
FOI/2021/0442 - Cataract surgery
-
FOI/2021/0445 - Fibreoptic endoscopic evaluation of swallowing